SCHEMBL31474516

SCHEMBL31474516

FC(F)(F)c1ccc(Oc2ncccc2Cl)cn1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 1/20 0.42
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ DRD1 P21728 3/20 0.40
▸ LMNA P02545 3/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ XBP1 P17861 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ RAB9A P51151 1/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ BLM P54132 1/20 0.39
▸ SCN9A Q15858 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ TRPV4 Q9HBA0 1/20 0.39
▸ TSHR P16473 1/20 0.38
▸ APEX1 P27695 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26109314 1.00 GRM5 (0.42) GRM5SMN1; SMN2DRD1LMNAMEN1
SCHEMBL20394456 0.88 GRM5 (0.39) GRM5SMN1; SMN2LMNAMEN1MAPT
SCHEMBL20406192 0.84 PDE10A (0.41) GRM5DRD1MAPTSCN9AALDH1A1
SCHEMBL20406540 0.83 LMNA (0.37) GRM5DRD1LMNAMEN1KMT2A
SCHEMBL20406227 0.82 PDE10A (0.40) GRM5DRD1MAPTSCN9AALDH1A1
SCHEMBL26107379 0.82 RAB9A (0.41) SMN1; SMN2DRD1LMNAMAPTKMT2A
SCHEMBL30591776 0.82 GRM5 (0.41) GRM5SMN1; SMN2LMNAMEN1MAPT
SCHEMBL30592014 0.82 RAB9A (0.41) SMN1; SMN2DRD1LMNAMAPTKMT2A
SCHEMBL20406633 0.82 GRM5 (0.41) GRM5SMN1; SMN2LMNAMEN1MAPT
SCHEMBL18661504 0.82 PDE10A (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250206722-A1 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS THE SCRIPPS RESEARCH INSTITUTE 2025-06-26 — — US disclosed
CN-119403551-A Small molecule inhibitors of TEA domain family members 斯克里普斯研究学院 2025-02-07 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250206722-A1 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS YAP1, TEAD1, TEAD2 GRM5 4228/4885SMN1; SMN2 2064/4885DRD1 4360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback